Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 11

1512P - Pain in patients with desmoid fibromatosis (DF)

Date

10 Sep 2022

Session

Poster session 11

Topics

Tumour Site

Sarcoma

Presenters

Nicolas Penel

Citation

Annals of Oncology (2022) 33 (suppl_7): S681-S700. 10.1016/annonc/annonc1073

Authors

N. Penel1, S. Bonvalot2, A. Bimbai3, A. Italiano4, D. Orbach5, B. Verret6, M. Toulmonde7, A. Dufresne8, J. Bay9, L. Chaigneau10, J.E. Kurtz11, E. Bompas12, S. Salas13, F. Bertucci14, C. Guillemet15, T. Ryckewaert16, J. Thery17, M. Le Deley3, J. Blay18, A. Le Cesne19

Author affiliations

  • 1 Medical Oncology Department, Centre Oscar Lambret, 59020 - Lille/FR
  • 2 Department Of Surgery, Institut Curie, 75005 - Paris/FR
  • 3 Methodology And Biostatistics, Centre Oscar Lambret, 59020 - Lille/FR
  • 4 Department Of Medical Oncology,, Institut Bergonie, 33076 - Bordeaux/FR
  • 5 Siredo Oncology Center, Institut Curie, 75005 - Paris/FR
  • 6 Department Of Medical Oncology, Institut Gustave Roussy, 94805 - VILLEJUIF/FR
  • 7 Medical Oncology Department, Institute Bergonié - Centre Régional de Lutte Contre le Cancer (CLCC), 33000 - Bordeaux/FR
  • 8 Medical Oncology Dept, Centre Léon Bérard, 69008 - Lyon/FR
  • 9 Clinical Hematology Department, CHU de Clermont-Ferrand, Clermont-Ferrand/FR
  • 10 Oncology, CHRU Besancon - Hopital Jean Minjoz, 25030 - Besancon/FR
  • 11 Medical Oncology Department, CHU Hautepierre, 67200 - Strasbourg/FR
  • 12 Oncology Dept., ICO Institut de Cancerologie de l'Ouest René Gauducheau, 44805 - Saint-Herblain/FR
  • 13 Oncology, AP-HM - CHU La Timone Enfants, 13385 - Marseille/FR
  • 14 13, IPC - Institut Paoli-Calmettes, 13009 - Marseille/FR
  • 15 Medical Oncology Departmen, Centre Henri Becquerel, 76038 - Rouen/FR
  • 16 Medical Oncology Departmen, Centre Oscar Lambret, 59020 - Lille/FR
  • 17 Clinical Research Department, Centre Oscar Lambret, 59020 - Lille/FR
  • 18 Medicine Department, Centre Léon Bérard, 69008 - Lyon/FR
  • 19 Medical Oncology Department, Gustave Roussy - Cancer Campus, 94805 - Villejuif/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1512P

Background

DF can be painful. However, data on pain prevalence, associated factors and prognostic value are sparse.

Methods

ALTITUDES is a nationwide prospective clinico-pathological database including 618 pts with DF diagnosed in France from January 2016 to December 2020 (NCT02867033). Pain was prospectively collected, as binary data (pain: yes/no) and as continuous data (numerical rating scale NRS: from 0 to 10). Herein, we describe pain at diagnosis (up to 6 months after diagnosis) in pts with active surveillance (AS), surgery or systemic treatment as 1st-line approach. We identified factors associated with pain at diagnosis using univariate and multivariate logistic regression. We used Kaplan-Meier method and Cox models to explore the prognostic value of pain in term of event-free survival (EFS).

Results

Data on pain at diagnosis was available in 382 pts. The study population included 265 women (69%); the median age was 40.2 (0.1-78.4). The 1st-line strategy was ASin 273 pts (71%), surgery in 66 pts (17%), and systemic treatment in 43 pts (11%). At diagnosis, there was no pain in 245 pts (64%), mild pain (NRS=1 or 2) in 35 (9%), severe pain (NRS≥3) in 58 (15%), and pain without NRS available in 44 (11%). In multivariate analysis , pain was more frequent in pts with DF arising in neck and shoulder (OR=3.0; 95% confidence interval, 1.2-7.1), and less frequent in abdominal wall DF (OR=0.5; 0.3-0.8) or intra-abdominal DF (OR=0.4; 0.2-0.8) compared to other sites (p<0.001). a significant association was also observed with larger DF (>50 mm: OR=1.8; 1.2-2.8; p=0.011). In univariate analysis, presence of pain at diagnosis was associated with short EFS (HR=2.0; 1.3-2.9; p=0.006); the 3-year EFS rate was 53% in pts with pain versus 72% in pts with no pain. In multivariate analysis controlling for DF size and first-line strategy, presence of pain remained associated with EFS (HR=1.8; 1.2-2.6; p=0.003). We did not observe any significant heterogeneity of pain effect on EFS across 1st-line treatment groups (interaction test, p=0.28).

Conclusions

Pain at diagnosis in DF pts is associated with site (especially, neck and shoulder location) and large size and is associated with worse prognosis whatever the 1st-line strategy.

Clinical trial identification

NCT02867033.

Editorial acknowledgement

Legal entity responsible for the study

Centre Oscar Lambret.

Funding

Institut Curie, Ligue contre le Cancer, INTERSARC.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.